The presence of CD133 was evaluated in the plasma membrane, cytoplasm, and nucleus of the tumor cells (Figure 1A), as well as the angioinvasive parts (Figure 1B) by immunohistochemical staining. This evidence concerns the gene PROM1 and neoplasm.